US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class II · Moderate risk Terminated

Edta Disodium 15%

Reason Lack of Assurance of Sterility

Medaus, Inc. D-1182-2016
Class II · Moderate risk Terminated

Dmso 99.9

Reason Lack of Assurance of Sterility

Medaus, Inc. D-1181-2016
Class II · Moderate risk Terminated

Dmps 50mg/Ml

Reason Lack of Assurance of Sterility

Medaus, Inc. D-1180-2016
Class II · Moderate risk Terminated

Dexpanthenol 250mg/Ml

Reason Lack of Assurance of Sterility

Medaus, Inc. D-1178-2016
Class II · Moderate risk Terminated

Cesium Chloride 600mg/Ml

Reason Lack of Assurance of Sterility

Medaus, Inc. D-1177-2016
Class II · Moderate risk Terminated

Calcium Sodium Edta 300mg/Ml

Reason Lack of Assurance of Sterility

Medaus, Inc. D-1176-2016
Class II · Moderate risk Terminated

B-Complex 50 in Nacl 0.9%

Reason Lack of Assurance of Sterility

Medaus, Inc. D-1172-2016
Class II · Moderate risk Terminated

B-Complex Without B12 W/Pres

Reason Lack of Assurance of Sterility

Medaus, Inc. D-1171-2016
Class II · Moderate risk Terminated

B-Complex Without B12

Reason Lack of Assurance of Sterility

Medaus, Inc. D-1170-2016
Class II · Moderate risk Terminated

B-Complex

Reason Lack of Assurance of Sterility

Medaus, Inc. D-1169-2016
Class II · Moderate risk Terminated

B-Complex #3 W/Pres

Reason Lack of Assurance of Sterility

Medaus, Inc. D-1168-2016
Class II · Moderate risk Terminated

B-Complex #3

Reason Lack of Assurance of Sterility

Medaus, Inc. D-1167-2016
Class III · Low risk Terminated

Hyoscyamine Sulfate Sublingual Tablets

Reason Chemical Contamination: Bottles may contain broken dessicants

Virtus Pharmaceuticals, Llc NDC 76439-0309-10 D-1044-2016
Class I · High risk Terminated

Super Samurai-X

Reason Marketed without an approved NDA/ANDA: FDA sample analyses revealed the presence of undeclared sildenafil and/or its analogs in products marketed as dietary supplements

SOS Telecom Inc. D-0104-2017
Class I · High risk Terminated

Ginseng Power-X

Reason Marketed without an approved NDA/ANDA: FDA sample analyses revealed the presence of undeclared sildenafil and/or its analogs in products marketed as dietary supplements

SOS Telecom Inc. D-0103-2017
Class I · High risk Terminated

Ninja-X

Reason Marketed without an approved NDA/ANDA: FDA sample analyses revealed the presence of undeclared sildenafil and/or its analogs in products marketed as dietary supplements

SOS Telecom Inc. D-0102-2017
Class I · High risk Terminated

Tiger-X

Reason Marketed without an approved NDA/ANDA: FDA sample analyses revealed the presence of undeclared sildenafil and/or its analogs in products marketed as dietary supplements

SOS Telecom Inc. D-0101-2017
Class II · Moderate risk Terminated

1% Clotrimazol cream

Reason CGMP Deviations

Profarma Distributors LLC D-1043-2016
Class II · Moderate risk Terminated

VERMOX Tablets 500 mg

Reason CGMP Deviations

Profarma Distributors LLC D-1042-2016